Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Research & Development: 2014-2024

Historic Research & Development for Ocugen (OCGN) over the last 11 years, with Dec 2024 value amounting to $32.1 million.

  • Ocugen's Research & Development rose 37.51% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.4 million, marking a year-over-year increase of 18.20%. This contributed to the annual value of $32.1 million for FY2024, which is 18.82% down from last year.
  • Per Ocugen's latest filing, its Research & Development stood at $32.1 million for FY2024, which was down 18.82% from $39.6 million recorded in FY2023.
  • Over the past 5 years, Ocugen's Research & Development peaked at $56.2 million during FY2022, and registered a low of $6.4 million during FY2020.
  • For the 3-year period, Ocugen's Research & Development averaged around $42.6 million, with its median value being $39.6 million (2023).
  • Its Research & Development has fluctuated over the past 5 years, first soared by 452.53% in 2021, then dropped by 29.53% in 2023.
  • Over the past 5 years, Ocugen's Research & Development (Yearly) stood at $6.4 million in 2020, then surged by 452.53% to $35.1 million in 2021, then spiked by 59.96% to $56.2 million in 2022, then decreased by 29.53% to $39.6 million in 2023, then declined by 18.82% to $32.1 million in 2024.